RecruitingNot ApplicableNCT07579455

Acute Pharmacokinetics of Create Wellness Gummies in Healthy Adults


Sponsor

University of Oklahoma

Enrollment

16 participants

Start Date

Jun 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to compare blood creatine levels following acute oral supplementation of Create Wellness creatine gummies to creatine monohydrate powder.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Inclusion Criteria5

  • Adults between the ages of 18-45 yrs
  • Body mass index of <35 kg/m2
  • Recreationally active \[(≥30 minutes of moderate-intensity physical activity per week as defined by the International Physical Activity Questionnaire (IPAQ)\]
  • Healthy and free from major diseases as determined from screening call and health history questionnaire.
  • Agrees to complete pre-assessment guidelines (8-hour fast from caloric foods and beverages, 24-hour abstention from vigorous physical activity, caffeine, alcohol, and tobacco).

Exclusion Criteria4

  • Chronic kidney disease, liver disease, chronic obstructive pulmonary disease, or cancer.
  • Currently using medications that may directly impact the primary outcomes including: diuretics and corticosteroids).
  • Currently using creatine monohydrate
  • Severely impaired hearing or speech or inability to speak English.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTCreate Wellness Creatine Gummies

Create Wellness creatine gummies provide 4.5 grams of creatine monohydrate in a 3 gummy serving size.

DIETARY_SUPPLEMENTCreatine Monohydrate Powder

4.5 grams of creatine monohydrate powder (Creapure®) dissolved in 240 mL of water.


Locations(1)

ATHENA Laboratory

Norman, Oklahoma, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07579455